Dr. Reddy's Laboratories Aktie
| 13,98USD | -0,32USD | -2,20% |
WKN: 659157 / ISIN: US2561352038
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 500,00 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 21 650 | 22 739 | 24 795 | 25 863 | 27 048 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,11 | 0,11 | 0,12 | 0,12 | 0,12 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 723 | 2 028 | 2 400 | 2 518 | 2 974 |
| Summe Anlagevermögen | 1 347 | 1 604 | 1 464 | 1 398 | 1 672 |
| Summe Aktiva | 3 070 | 3 631 | 3 864 | 3 916 | 4 646 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 292 | 415 | 447 | 164 | 240 |
| Summe Fremdkapital | 1 021 | 1 264 | 1 350 | 1 106 | 1 283 |
| Summe Eigenkapital | 2 049 | 2 367 | 2 514 | 2 811 | 3 364 |
| Summe Passiva | 3 070 | 3 631 | 3 864 | 3 916 | 4 646 |
Adresse
| Door No. 8-2-337, 500034 Hyderabad | |
| Telefon | +91 (40) 49002900 |
| Internet | http://www.drreddys.com |
Management
|
Alpna H. Seth
Independent Non-Executive Director |
|
Archana Bhaskar
Chief Human Resources Officer |
|
Arun M. Kumar
Independent Non-Executive Director |
|
B. Phanimitra
Chief Digital & Information Officer |
|
Claudio Albrecht
Independent Non-Executive Director |
|
Deepak Sapra
Chief Executive Officer-API & Services |
|
Erez Israeli
Chief Executive Officer |
|
Gunupati Venkateswara Prasad
Co-Chairman & Managing Director |
|
Jayanth Sridhar
Global Head-Biologics |
|
Kodumudi P. Krishnan
Independent Non-Executive Director |
|
Kumar Randhir Singh
Secretary, Compliance Officer & Head-CSR |
|
Kundan Kumar Jha
Assistant Secretary |
|
Leo Puri
Lead Independent Non-Executive Director |
|
M. V. Ramana
CEO-India & Emerging Markets Branded Markets |
|
Milan Kalawadia
Chief Executive Officer-North America |
|
Patrick Rudolf Aghanian
Chief Executive Officer-European Generics |
|
Penny Wan
Independent Non-Executive Director |
|
Richa Periwal
Head-Investor Relations & Analytics |
|
Sanjiv Soshil Mehta
Independent Non-Executive Director |
|
Satish Kallam Reddy
Co-Chairman |
|
Shikha Sanjaya Sharma
Independent Non-Executive Director |
|
Vivek Mittal
Global General Counsel |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
